Entdecken

Alpha-1 antitrypsin deficiency and replacement therapy - Current developments and clinical significa
4,95 € *

inkl. MwSt. zzgl. Versandkosten

Sofort versandfertig, Lieferzeit ca. 1-3 Werktage

  • UNI-MED, Bremen
  • Andreas Rembert Koczulla
  • KNV91556942
  • 9783837424249
Alpha-1 antitrypsin deficiency (AATD) is one of the most common genetic defects in Europe. As a... mehr
Produktinformationen "Alpha-1 antitrypsin deficiency and replacement therapy - Current developments and clinical significa"
Alpha-1 antitrypsin deficiency (AATD) is one of the most common genetic defects in Europe. As a consequence of the lowered A1AT serum level, the protease-antiprotease balance is disturbed, which among others can lead to an early development of emphysema. The underdiagnosis of AATD is another problematic aspect because it is suspected that only about 5 to 15% of all homozygous patients are currently identified. Usually there is also a diagnostic delay, which can be 5 years or more.
This textbook provides an overview of AATD with causes and genetics, diagnosis and therapy, the role of comorbidities and further topics such as vaccinations, sport and physical activities as well as the very complex aspects of a lung transplant. The increasing importance of imaging is addressed as well as the overall clinical evaluation and the need for follow-up examinations. The result is a very practice-oriented volume that will be very helpful in everyday clinical practice in the care of patients with AATD.
Weiterführende Links zu "Alpha-1 antitrypsin deficiency and replacement therapy - Current developments and clinical significa"
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Alpha-1 antitrypsin deficiency and replacement therapy - Current developments and clinical significa"
Bewertung schreiben
Bewertungen werden nach Überprüfung freigeschaltet.
Bitte geben Sie die Zeichenfolge in das nachfolgende Textfeld ein.

Die mit einem * markierten Felder sind Pflichtfelder.

Zuletzt angesehen